Morgan Stanley’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $124K | Sell |
131,393
-510,236
| -80% | -$483K | ﹤0.01% | 6051 |
|
2025
Q1 | $296K | Buy |
641,629
+115,479
| +22% | +$53.2K | ﹤0.01% | 5568 |
|
2024
Q4 | $389K | Buy |
526,150
+71,173
| +16% | +$52.6K | ﹤0.01% | 5527 |
|
2024
Q3 | $714K | Buy |
454,977
+100,941
| +29% | +$158K | ﹤0.01% | 5232 |
|
2024
Q2 | $595K | Buy |
354,036
+109,827
| +45% | +$185K | ﹤0.01% | 5210 |
|
2024
Q1 | $586K | Sell |
244,209
-1,591,167
| -87% | -$3.82M | ﹤0.01% | 5237 |
|
2023
Q4 | $2.81M | Buy |
1,835,376
+1,595,756
| +666% | +$2.44M | ﹤0.01% | 4746 |
|
2023
Q3 | $261K | Sell |
239,620
-34,923
| -13% | -$38.1K | ﹤0.01% | 5461 |
|
2023
Q2 | $629K | Buy |
274,543
+76,239
| +38% | +$175K | ﹤0.01% | 5103 |
|
2023
Q1 | $482K | Buy |
198,304
+62,462
| +46% | +$152K | ﹤0.01% | 5279 |
|
2022
Q4 | $259K | Sell |
135,842
-33,241
| -20% | -$63.5K | ﹤0.01% | 5560 |
|
2022
Q3 | $405K | Sell |
169,083
-399,825
| -70% | -$958K | ﹤0.01% | 5371 |
|
2022
Q2 | $1.06M | Buy |
568,908
+382,326
| +205% | +$710K | ﹤0.01% | 4984 |
|
2022
Q1 | $390K | Buy |
186,582
+78,114
| +72% | +$163K | ﹤0.01% | 5554 |
|
2021
Q4 | $427K | Buy |
108,468
+8,893
| +9% | +$35K | ﹤0.01% | 5639 |
|
2021
Q3 | $479K | Sell |
99,575
-35,186
| -26% | -$169K | ﹤0.01% | 5523 |
|
2021
Q2 | $619K | Sell |
134,761
-570,377
| -81% | -$2.62M | ﹤0.01% | 5387 |
|
2021
Q1 | $4.14M | Sell |
705,138
-1,374,999
| -66% | -$8.07M | ﹤0.01% | 3604 |
|
2020
Q4 | $7.11M | Buy |
2,080,137
+691,695
| +50% | +$2.37M | ﹤0.01% | 2874 |
|
2020
Q3 | $2M | Sell |
1,388,442
-627,739
| -31% | -$904K | ﹤0.01% | 3659 |
|
2020
Q2 | $4.02M | Buy |
2,016,181
+1,856,279
| +1,161% | +$3.7M | ﹤0.01% | 2897 |
|
2020
Q1 | $312K | Sell |
159,902
-282,344
| -64% | -$551K | ﹤0.01% | 4642 |
|
2019
Q4 | $1.84M | Sell |
442,246
-32,606
| -7% | -$135K | ﹤0.01% | 4112 |
|
2019
Q3 | $1.43M | Buy |
474,852
+279,545
| +143% | +$841K | ﹤0.01% | 4065 |
|
2019
Q2 | $1.23M | Buy |
195,307
+119,611
| +158% | +$753K | ﹤0.01% | 4112 |
|
2019
Q1 | $421K | Sell |
75,696
-65,091
| -46% | -$362K | ﹤0.01% | 4653 |
|
2018
Q4 | $935K | Buy |
140,787
+51,822
| +58% | +$344K | ﹤0.01% | 4323 |
|
2018
Q3 | $950K | Sell |
88,965
-58,240
| -40% | -$622K | ﹤0.01% | 4576 |
|
2018
Q2 | $1.77M | Buy |
147,205
+40,700
| +38% | +$489K | ﹤0.01% | 4194 |
|
2018
Q1 | $912K | Sell |
106,505
-5,494
| -5% | -$47K | ﹤0.01% | 4606 |
|
2017
Q4 | $1.11M | Buy |
111,999
+7,628
| +7% | +$75.4K | ﹤0.01% | 4468 |
|
2017
Q3 | $1.28M | Buy |
104,371
+32,557
| +45% | +$400K | ﹤0.01% | 4259 |
|
2017
Q2 | $1.18M | Sell |
71,814
-102,951
| -59% | -$1.69M | ﹤0.01% | 4250 |
|
2017
Q1 | $2.51M | Buy |
174,765
+32,276
| +23% | +$463K | ﹤0.01% | 3612 |
|
2016
Q4 | $1.97M | Buy |
142,489
+21,709
| +18% | +$300K | ﹤0.01% | 3943 |
|
2016
Q3 | $2.18M | Buy |
120,780
+97,904
| +428% | +$1.77M | ﹤0.01% | 3436 |
|
2016
Q2 | $328K | Sell |
22,876
-25,025
| -52% | -$359K | ﹤0.01% | 4671 |
|
2016
Q1 | $573K | Buy |
47,901
+44,436
| +1,282% | +$532K | ﹤0.01% | 4344 |
|
2015
Q4 | $47K | Sell |
3,465
-13,492
| -80% | -$183K | ﹤0.01% | 5739 |
|
2015
Q3 | $182K | Sell |
16,957
-20,523
| -55% | -$220K | ﹤0.01% | 5127 |
|
2015
Q2 | $302K | Buy |
37,480
+4,581
| +14% | +$36.9K | ﹤0.01% | 5024 |
|
2015
Q1 | $218K | Sell |
32,899
-104,772
| -76% | -$694K | ﹤0.01% | 5162 |
|
2014
Q4 | $876K | Buy |
137,671
+116,421
| +548% | +$741K | ﹤0.01% | 4252 |
|
2014
Q3 | $210K | Sell |
21,250
-20,754
| -49% | -$205K | ﹤0.01% | 5119 |
|
2014
Q2 | $473K | Buy |
42,004
+20,408
| +94% | +$230K | ﹤0.01% | 4614 |
|
2014
Q1 | $262K | Sell |
21,596
-11,247
| -34% | -$136K | ﹤0.01% | 4963 |
|
2013
Q4 | $414K | Sell |
32,843
-13,748
| -30% | -$173K | ﹤0.01% | 4585 |
|
2013
Q3 | $776K | Sell |
46,591
-171,744
| -79% | -$2.86M | ﹤0.01% | 4008 |
|
2013
Q2 | $3.32M | Buy |
+218,335
| New | +$3.32M | ﹤0.01% | 2714 |
|